Insulinoma in tuberous sclerosis an entity not to be missed

8Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Pancreatic neuroendocrine tumors are rare with an incident rate of 5 cases per million individuals. Tuberous sclerosis complex is an autosomal dominant disease. This disease involves multisystem and occurs in one out of every 6,000-10,000 individuals. In this study, we describe a 47-year-old male known tuberous sclerosis patient with an insulinoma. The tumor was incidentally detected in follow-up imaging for a previous ampulla of Vater tubular adenoma. However, the patient reported symptoms of hypoglycemia. The insulinoma was enucleated successfully. Histopathology revealed a well-differentiated, grade one neuroendocrine tumor measuring around 2 cm in diameter. Seven cases were reported in the literature of tuberous sclerosis-associated insulinoma. The 7 reported cases had different hypoglycemia related symptoms. The reported tumors varied in size and location on the pancreas. This paper details the eighth case worldwide where an insulinoma occurred in a tuberous sclerosis patient.

Cite

CITATION STYLE

APA

Al Qahtani, M. S., Bojal, S. A., Alqarzaie, A. A., & Alqahtani, A. A. (2021). Insulinoma in tuberous sclerosis an entity not to be missed. Saudi Medical Journal, 42(3), 332–337. https://doi.org/10.15537/SMJ.2021.42.3.20200490

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free